跳至主要内容
临床试验/NCT01192438
NCT01192438已完成不适用

A Pilot Study to Evaluate Magnetic Resonance Thermal Image-guided Laser-Induced Interstitial Thermal Therapy for Focal Ablation of Prostate Cancer

University of Chicago1 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2010年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
9
试验地点
1
主要终点
Number of patients with adverse events

研究概览

简要总结

The purpose of this study is to evaluate the safety of MRI-guided laser-induced thermal therapy of biopsy confirmed low-risk prostate cancer.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
45 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Male, 45 years of age or older
  • •Diagnosis of prostate adenocarcinoma
  • •Clinical stage T1c or T2a
  • •Gleason score of 7 or less
  • •A minimum of 12 biopsy cores sampled during diagnostic biopsy
  • •Three or fewer biopsy cores with prostate cancer
  • •No single biopsy core with greater than 50% of tumor involvement
  • •A radiographically visible prostate lesion on MRI with concordance to biopsy sextant
  • •A documented Karnofsky performance status of at least 70
  • •Estimated survival of 20 years or greater, as determined by treating physician
  • •Ability to give informed consent

排除标准

  • •Previous surgery, radiation, or androgen deprivation therapy for prostate cancer
  • •Presence of any condition (e.g., metal implant, shrapnel) not compatible with MRI
  • •History of previous pelvic radiation
  • •Severe lower urinary tract symptoms as measured by an International Prostate Symptom Score (IPSS) of 20 or greater. (See Appendix A)
  • •History of other primary non-skin malignancy within previous three years

研究组 & 干预措施

Procedure/surgery

Experimental

干预措施: Laser-based thermotherapy (Procedure)

结局指标

主要结局

Number of patients with adverse events

时间窗: Within 6 months of the procedure

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验